Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 12, 2016
Considering Age Variation When Coining Drugs as High versus Low Hepatic Extraction RatioFarzaneh Salem, Khaled Abduljalil, Yoshiteru Kamiyama, et al.The Journal of Pharmacology and Experimental Therapeutics|April 17, 2004
Unique properties of a renal sulfotransferase, St1d1, in dopamine metabolismMiki Shimada, Reiko Terazawa, Yoshiteru Kamiyama, et al.Journal of Biochemistry|February 1, 2002
A hydroxysteroid sulfotransferase, st2b2, is a skin cholesterol sulfotransferase in miceMiki Shimada, Yoshiteru Kamiyama, Akira Sato, et al.Drug Metabolism and Pharmacokinetics|September 11, 2007
Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNAYoshiteru Kamiyama, Tsutomu Matsubara, Kouichi Yoshinari, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 3, 2014
Analysis of the impact of controlled release formulations on oral drug absorption, gut wall metabolism and relative bioavailability of CYP3A substrates using a physiologically-based pharmacokinetic modelAndrés Olivares-Morales, Yoshiteru Kamiyama, Adam S Darwich, et al.Oncotarget|May 10, 2019
Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD acute myeloid leukemiaYoko Ueno, Masamichi Mori, Yoshiteru Kamiyama, et al.Investigational New Drugs|July 2, 2014
In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3)Aya Kikuchi, Takashi Furutani, Hidenori Azami, et al.Cytotherapy|October 25, 2024
Using qPCR and ddPCR to study biodistribution of cell therapy products: a multi-site evaluationEriko Fujita, Syunsuke Yamamoto, Takeshi Hanada, et al.Regenerative Therapy|July 26, 2021
Biodistribution studies for cell therapy products: Current status and issuesYoshiteru Kamiyama, Yoichi Naritomi, Yuu Moriya, et al.Cytotherapy|June 12, 2021
Non-clinical assessment of cell therapy products: the perspective from five Asian countries/regions based on regulatory guidelines and the underpinning rationalesTomohiro Yoneda, Byung H Choi, Pawan K Gupta, et al.Pageof 1